|
NIBSC 19/166 Insulin-like Growth Factor I, for Immunoassay
- 英文名稱：Insulin-like Growth Factor I, for Immunoassay
- 品牌：NIBSC
- 產(chǎn)地：國外
- 型號：詳詢
- 貨號：19/166
- 發(fā)布日期： 2022-08-29
- 更新日期： 2024-08-12
產(chǎn)品詳請
| 產(chǎn)地 | 國外 |
| 品牌 | NIBSC |
| 貨號 | 19/166 |
| 用途 | 詳詢 |
| 英文名稱 | Insulin-like Growth Factor I, for Immunoassay |
| 包裝規(guī)格 | 詳詢 |
| 純度 | 詳詢% |
| CAS編號 | |
| 別名 | Insulin-like Growth Factor I, for Immunoassay |
| 分子式 | 詳詢 |
| 是否進(jìn)口 |
Product description：Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)
Product number：19/166
Category：Diagnostics/Protein Hormones and Endocrine Products
Keywords：IGF-I, growth, endocrine, immunoassay
Type of standard：International Standard
The WHO International Standard for Insulin-like Growth Factor-I (IGF-I), recombinant, human, is the primary reference material for the calibration of IGF-I immunoassays. This preparation, coded 19/166, containing recombinant human IGF-I, was ampouled and evaluated for its suitability to serve as a WHO International Standard by international collaborative study. It was established as the 2nd International Standard for Insulin-like growth factor-I, recombinant, human, by the Expert Committee for Biological Standardization of the World Health Organization in October 2020. It replaces the 1st International Standard, for Insulin-like growth factor-I (IGF-I), recombinant, human, coded 02/254.
Product number：19/166
Category：Diagnostics/Protein Hormones and Endocrine Products
Keywords：IGF-I, growth, endocrine, immunoassay
Type of standard：International Standard
The WHO International Standard for Insulin-like Growth Factor-I (IGF-I), recombinant, human, is the primary reference material for the calibration of IGF-I immunoassays. This preparation, coded 19/166, containing recombinant human IGF-I, was ampouled and evaluated for its suitability to serve as a WHO International Standard by international collaborative study. It was established as the 2nd International Standard for Insulin-like growth factor-I, recombinant, human, by the Expert Committee for Biological Standardization of the World Health Organization in October 2020. It replaces the 1st International Standard, for Insulin-like growth factor-I (IGF-I), recombinant, human, coded 02/254.
相關(guān)產(chǎn)品：
